Veteran Healthcare CEO Joins Alerje Advisory Board
David Esposito has built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers. We’re excited to have his expertise on our already impressive advisory board. Here’s some insight from David on why he chose to support Alerje:
“Javier is doing a great job leading the team at Alerje to make a significant, positive difference in the lives of individuals and families impacted by food allergies. The technology being developed by Alerje will enable better communication among caregivers, improved health literacy, and the platform to build a virtual community to support those impacted by food allergies. I am grateful to support the Alerje team in sharing my experience in allergy diagnostics and building early-stage, innovative health care companies.”
About David Esposito:
As a CEO, David led Armune BioScience in it’s 2017 acquisition by Exact Sciences. Prior to this exit, Esposito was the president and general manager of Phadia U.S. Inc., a specialty diagnostics company. He is credited with helping to drive significant growth for that company in the U.S. market and played a leadership role in the sale of Phadia to ThermoFisher Scientific for $3.5 billion in 2011. Prior to that, he worked for 15 years in several key roles in marketing and commercial strategy at Merck & Co.
David is a combat veteran, husband, father, business executive, and creator of the award-winning resources you’ll find on this website. He is dedicated to developing programs and resources that help people be their best for those they care about most at home, work, and in the community.
David’s character and leadership skills were cultivated at West Point and through leadership assignments in the US Army Infantry. As an airborne ranger infantry officer, David led a rifle platoon of 39 men with the 101st Airborne Division through several combat operations in the Gulf War. He was recognized with a Bronze Star for combat operations in February 1991.
About Alerje:
Alerje is building an “Treatment x Lifestyle” IoMT platform to improve the overall quality of life of those affected by food allergies.
